Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder

NCT03554174 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Low Dose Psilocybin
DRUG: Placebo
DRUG: Medium Dose Psilocybin

Sponsor

Yale University

Collaborators

[object Object]